Effects of Urban Afforestation Activity on Mood, Stress, and Anxiety

Healthy Clinical Trial

Official title:

Effects of an Urban Afforestation Activity on Mood, Stress, and Anxiety of Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05384301
• Other study ID #: AfforestMood
• Status: Completed
• Phase: N/A
• Start date: May 25, 2022
• Est. completion date: June 5, 2022

Study information

• Verified date: June 2022
• Source: Universidad de Granada
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This single-group pretest-posttest clinical trial aims to evaluate the effects of a single-session afforestation activity on mood, stress, and anxiety in a sample of adults.

Description:

The participants will perform an afforestation activity for a single session of 90 minutes. The therapist will direct the participants' attention to the visual, auditory, olfactory, and tactile features of the surrounding environment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 154
• Est. completion date: June 5, 2022
• Est. primary completion date: June 5, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Adults between 18 and 65 years.
• Any sex and gender.

Exclusion Criteria:

• Intake of any psychotropic medication.
• Other severe or medically unstable diseases that may interfere with participation.
• Severe cognitive impairment (Mini-Mental State Examination score < 17 out of 30 points).
• Severe mental disorders in the acute phase or symptomatic phase.
• Severe intellectual disability.
• Behavioural alterations as this may interfere with their participation.

Related Conditions & MeSH terms

• Anxiety Disorders
• Healthy

Intervention

Other:
• Urban Afforestation Program
An afforestation program based on land cultivation and transplantation of several plants for 90 minutes will be implemented.

Locations

Country	Name	City	State
Spain	University of Granada, Faculty of Health Sciences	Granada	Andalusia

Sponsors (1)

Lead Sponsor	Collaborator
Universidad de Granada

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mood	The Spanish adaptation of the 30-item Short Form of the Profile of Mood States will be utilised. There are five questions situated under each mood factor of Anger, Fatigue, Vigour, Friendliness, Tension, and Depressed Mood, which will be rated on a five-point scale starting from 0 indicating "not at all" up to 4 indicating "a lot" to evaluate the current feelings. Higher scores on the vigour and friendliness subscale indicate more positive mood, and higher scores on the remaining subscales indicate more negative mood.	Change from baseline the total mood disturbance after 90 minutes.
Secondary	State stress	The perceived stress will be assessed by the 100-mm Visual Analogue Scale, where endpoints are labelled as "None" and "As bad as it could be" from left to right. The scale will yield a single quantitative variable regarded as the state stress score, which is measured by the distance between the far-left end and the participant's mark on the line in millimetres. Lower scores indicate less stress at the moment.	Change from baseline state stress after 90 minutes.
Secondary	State anxiety	The 100-mm Visual Analogue Scale for state anxiety will be employed. The endpoints of the scale are labelled as "None" and "As bad as it could be" from left to right. The distance in millimetres between the far-left end and the participant's mark will be regarded as the state anxiety score. Lower scores indicate less anxiety at the moment.	Change from baseline state anxiety after 90 minutes.